134 related articles for article (PubMed ID: 2470067)
1. Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth.
Bepler G; Zeymer U; Mahmoud S; Fiskum G; Palaszynski E; Rotsch M; Willey J; Koros A; Cuttitta F; Moody TW
Peptides; 1988; 9(6):1367-72. PubMed ID: 2470067
[TBL] [Abstract][Full Text] [Related]
2. Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues.
Mahmoud S; Palaszynski E; Fiskum G; Coy DH; Moody TW
Life Sci; 1989; 44(5):367-73. PubMed ID: 2536883
[TBL] [Abstract][Full Text] [Related]
3. The release of bombesin-like peptides from small cell lung cancer cells.
Moody TW; Korman LY
Ann N Y Acad Sci; 1988; 547():351-9. PubMed ID: 2853597
[TBL] [Abstract][Full Text] [Related]
4. Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist.
Patel KV; Schrey MP
J Mol Endocrinol; 1991 Feb; 6(1):71-8. PubMed ID: 1707628
[TBL] [Abstract][Full Text] [Related]
5. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.
Woll PJ; Rozengurt E
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1859-63. PubMed ID: 2450349
[TBL] [Abstract][Full Text] [Related]
6. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells.
Nyéki O; Rill A; Schon I; Orosz A; Schrett J; Bartha L; Nagy J
J Pept Sci; 1998 Dec; 4(8):486-95. PubMed ID: 9927255
[TBL] [Abstract][Full Text] [Related]
8. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Layton JE; Scanlon DB; Soveny C; Morstyn G
Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
[TBL] [Abstract][Full Text] [Related]
9. [Des-Met14]bombesin analogues function as small cell lung cancer bombesin receptor antagonists.
Staley J; Coy D; Taylor JE; Kim S; Moody TW
Peptides; 1991; 12(1):145-9. PubMed ID: 1646997
[TBL] [Abstract][Full Text] [Related]
10. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
Moody TW; Staley J; Zia F; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1992 Oct; 263(1):311-7. PubMed ID: 1328611
[TBL] [Abstract][Full Text] [Related]
11. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
[TBL] [Abstract][Full Text] [Related]
12. Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists.
Davis TP; Crowell S; Taylor J; Clark DL; Coy D; Staley J; Moody TW
Peptides; 1992; 13(2):401-7. PubMed ID: 1329046
[TBL] [Abstract][Full Text] [Related]
13. Characterization of ability of various substance P antagonists to inhibit action of bombesin.
Jensen RT; Heinz-Erian P; Mantey S; Jones SW; Gardner JD
Am J Physiol; 1988 Jun; 254(6 Pt 1):G883-90. PubMed ID: 2454035
[TBL] [Abstract][Full Text] [Related]
14. (D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists.
Merali Z; Merchant CA; Crawley JN; Coy DH; Heinz-Erian P; Jensen RT; Moody TW
Synapse; 1988; 2(3):282-7. PubMed ID: 2463692
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growth.
Everard MJ; Macaulay VM; Miller JL; Smith IE
Br J Cancer; 1992 Mar; 65(3):388-92. PubMed ID: 1373071
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of [Leu-13-psi-CH2NH-Leu14]-bombesin as a specific bombesin receptor antagonist on isolated smooth muscle cells.
Severi C; Coy DH; Jensen RT; Boschero L; Anania MC; Delle Fave G
J Pharmacol Exp Ther; 1989 Nov; 251(2):713-7. PubMed ID: 2478696
[TBL] [Abstract][Full Text] [Related]
17. New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo.
Orosz A; Schrett J; Nagy J; Bartha L; Schön I; Nyéki O
Int J Cancer; 1995 Jan; 60(1):82-7. PubMed ID: 7529212
[TBL] [Abstract][Full Text] [Related]
18. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide.
Carney DN; Cuttitta F; Moody TW; Minna JD
Cancer Res; 1987 Feb; 47(3):821-5. PubMed ID: 3026617
[TBL] [Abstract][Full Text] [Related]
19. Potent bombesin receptor antagonists distinguish receptor subtypes.
von Schrenck T; Wang LH; Coy DH; Villanueva ML; Mantey S; Jensen RT
Am J Physiol; 1990 Sep; 259(3 Pt 1):G468-73. PubMed ID: 2169207
[TBL] [Abstract][Full Text] [Related]
20. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
